I never gained the weight I lost during the liver detox
The analysis is based on results from the STEP 1 trial, published in 2021 in the New England Journal of Medicine , which showed the 2.4 mg dosage of semaglutide approved by the FDA for the treatment of obesity reduced body weight by an average of 14.9% along with reductions in several cardiovascular risk factors such as blood pressure and lipids
The primary composite endpoint (cardiovascular death or worsening heart failure) was reached in 9,9% of the tirzepatide arm versus 15,3% of the placebo arm (HR 0,62, p=0,026)
The optic nerve sends signals from the eye to the brain, allowing you to see
Compounded semaglutide, on the other hand, is not exactly the same
The difference depends on the dosages of tirzepatide and semaglutide that are being used for the comparison